Fact CheckerSign in

NCT07425041Completed

Effectiveness of Manual Lymphatic Drainage in the Physiotherapeutic Treatment of Migraine

Source: ClinicalTrials.gov · Last updated 29 Jul 2026

Brief summary (registry, in English)

Migraine is a highly prevalent neurological disorder associated with recurrent headache, disability, and reduced quality of life. In addition to pain, migraine is frequently accompanied by autonomic dysfunction, psychological comorbidities, and sleep disturbances. Manual lymphatic drainage (MLD) is a physiotherapy technique that may influence pain perception and autonomic regulation by promoting lymphatic and venous return and facilitating parasympathetic activity. The aim of this pilot clinical study is to evaluate the effectiveness of manual lymphatic drainage in patients with migraine. Participants will be allocated to an experimental group receiving manual lymphatic drainage or to a control group. Outcomes related to pain intensity, pressure pain thresholds, migraine-related disability, quality of life, psychological variables, sleep quality, and vital signs will be assessed at baseline, after the intervention, and during follow-up periods. This study seeks to provide preliminary evidence on the feasibility and potential clinical effects of manual lymphatic drainage as a non-pharmacological physiotherapy approach for migraine management.

Status (registry)
Completed
Study type
Interventional
Enrollment
20 (actual)
First submitted
13 Feb 2026
Start date
20 Mar 2026
Primary completion date
20 Apr 2026
Lead sponsor
Camilo Jose Cela University
Diseases
Migraine
NCT number
NCT07425041

What you commit to

  • Study type: Interventional
  • Participants enrolled: 20
  • From 20 Mar 2026 to the primary completion date, 20 Apr 2026
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Prior treatment

  • Participants currently taking prophylactic medication for migraine.

Other illness

  • Participants with arterial hypertension who are taking antihypertensive medication.

Other

  • Participants with fibromyalgia.

Who the study is looking for

  • Male or female, aged 20 to 55 years.
  • Clinical diagnosis of migraine and experiencing migraine episodes with a minimum frequency of 4 times per month.

Age in the registry: 20 years to 55 years · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
University Camilo José Cela
Coordinator of this site? Confirm its status
MadridSpainUnknown status

This page is information, not medical advice. Discuss any trial with your doctor.